{"title":"Zolbetuximab verlängert das Überleben bei Krebspatienten","authors":"","doi":"10.1055/a-2276-2085","DOIUrl":"https://doi.org/10.1055/a-2276-2085","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140375058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Das Pankreasadenokarzinom (PK) nimmt stetig an Häufigkeit zu und stellt bereits die dritthäufigste tumorbedingte Todesursache in Deutschland dar. Voraussichtlich rückt es bis 2030 auf den 2. Platz und bis 2050 gar auf den 1. Platz der krebsbedingten Todesfälle vor. Das Pankreaskarzinom wird generell spät diagnostiziert und die 5-Jahre-Überlebensrate liegt bei nur 10%. Wird das PK aber im Tumorstadium IA diagnostiziert und therapiert, so beträgt das 5-Jahresüberleben rund 80%. Früherkennungsinitiativen verfolgen deshalb das Ziel, Hochrisikopersonen zu identifizieren und das sporadische Pankreaskarzinom frühzeitig festzustellen. Personen über 50 mit neu diagnostiziertem Diabetes stehen dabei im Mittelpunkt des Interesses. Aktuelle Entwicklungen und Früherkennungsstrategien werden angesprochen.
{"title":"Früherkennung des sporadischen Pankreasadenokarzinoms","authors":"H. Scherübl","doi":"10.1055/a-2267-3513","DOIUrl":"https://doi.org/10.1055/a-2267-3513","url":null,"abstract":"Das Pankreasadenokarzinom (PK) nimmt stetig an Häufigkeit zu und stellt bereits die dritthäufigste tumorbedingte Todesursache in Deutschland dar. Voraussichtlich rückt es bis 2030 auf den 2. Platz und bis 2050 gar auf den 1. Platz der krebsbedingten Todesfälle vor. Das Pankreaskarzinom wird generell spät diagnostiziert und die 5-Jahre-Überlebensrate liegt bei nur 10%. Wird das PK aber im Tumorstadium IA diagnostiziert und therapiert, so beträgt das 5-Jahresüberleben rund 80%. Früherkennungsinitiativen verfolgen deshalb das Ziel, Hochrisikopersonen zu identifizieren und das sporadische Pankreaskarzinom frühzeitig festzustellen. Personen über 50 mit neu diagnostiziertem Diabetes stehen dabei im Mittelpunkt des Interesses. Aktuelle Entwicklungen und Früherkennungsstrategien werden angesprochen.","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140376456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Warum tun sich Krankenhäuser mit dem Patientenportal so schwer?","authors":"","doi":"10.1055/a-2264-9824","DOIUrl":"https://doi.org/10.1055/a-2264-9824","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140374781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gezieltere Krebstherapie durch Passagier-Gene","authors":"","doi":"10.1055/a-2189-7594","DOIUrl":"https://doi.org/10.1055/a-2189-7594","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140373601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prostatakarzinom: PSMA-PET besser als konventionelles Staging","authors":"","doi":"10.1055/a-2276-2434","DOIUrl":"https://doi.org/10.1055/a-2276-2434","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140375174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"lncRNA-Signatur eignet sich als Biomarker zur Früherkennung von Magenkrebs","authors":"","doi":"10.1055/a-2276-2136","DOIUrl":"https://doi.org/10.1055/a-2276-2136","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140375646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Besondere RNA unterdrückt Bildung von Brustkrebszellen","authors":"","doi":"10.1055/a-2189-7625","DOIUrl":"https://doi.org/10.1055/a-2189-7625","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140377659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nivolumab plus Chemotherapie bei nicht kleinzelligem Lungenkarzinom","authors":"","doi":"10.1055/a-2276-2280","DOIUrl":"https://doi.org/10.1055/a-2276-2280","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140374603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medikamentöse Therapiestrategien des Magenkarzinoms","authors":"Magdalena Scheck, S. Lorenzen","doi":"10.1055/a-2241-7192","DOIUrl":"https://doi.org/10.1055/a-2241-7192","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140374999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"H. pylori erhöht Risiko für Magenkrebs bei pathogenen Keimbahnvarianten","authors":"","doi":"10.1055/a-2276-2205","DOIUrl":"https://doi.org/10.1055/a-2276-2205","url":null,"abstract":"","PeriodicalId":333101,"journal":{"name":"TumorDiagnostik & Therapie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140375741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：